Press Releases
Knome Introduces the knoSYS™100
First Plug-and-Play Human Genome Interpretation System Big data technology breaks the genome interpretation bottleneck An in silico genetic testing “lab in a box” More than a dozen leading institutions join early access program CAMBRIDGE, MA – September 27, 2012 –...
Knome Appoints New VP Sales and Marketing
CAMBRIDGE, MA, USA, April 14, 2014 – Knome, Inc. has appointed Josh Forsythe as new Vice President, Sales and Marketing. Josh has over 10 years of executive sales and marketing experience at Golden Helix, Inc. where he helped transform the start-up into one of the...
GENALICE and Knome Form Strategic Partnership to Empower Rapid NGS Data Interpretation
HARDERWIJK, the Netherlands and CAMBRIDGE, Mass – January 12, 2015 – Today GENALICE and Knome, Inc. USA jointly announced a strategic partnership to offer their products together as a turn-key solution for those using next-generation sequencing (NGS) data to interpret...
Swiss Foundation for People with Rare Diseases Combines GENALICE and Knome Solutions to Improve DNA Analysis
HARDERWIJK, the Netherlands and CAMBRIDGE, Mass – October 1, 2014 – Today GENALICE and Knome, Inc. USA jointly announced that the Swiss Foundation for People with Rare Diseases has chosen to use their solutions in tandem to improve the Foundation’s processing and...
Knome Joins the Global Alliance for Genomics and Health
CAMBRIDGE, Mass – September 23, 2014 – Knome announced today that it has joined the Global Alliance for Genomics and Health, an alliance working to accelerate world-wide efforts to responsibly share and analyze large amounts of genomic and clinical data. Partners in...
Knome Makes Genomic Interpretation Accessible to Startups by Sponsoring LabCentral
CAMBRIDGE, Mass. – September 9, 2014 – Knome, Inc. today announced that it has entered a sponsorship agreement with LabCentral to provide the knoSYS® Informatics and Genomic Interpretation System to startups operating in LabCentral’s facility in Kendall Square....
Knome Launches Major Upgrade to Its Genomic Interpretation Platform, Targets Clinical and Translational Laboratories
Version 3 of the knoSYS® Platform lowers barriers to next-generation sequencing genomic testing through scalability, automation, performance, and collaboration. CAMBRIDGE, MA – August 12, 2014 – Knome, Inc. today announced the launch of the third generation of its...
Knome Launches the knoSYS™ 25 Human Genome Interpretation Platform
CAMBRIDGE, MA – March 26, 2014 – Knome, Inc. announced the launch of a new addition to the knoSYS human genome interpretation platform product line. Debuting today at the annual meeting of the American College of Medical Genetics and Genomics in Nashville, Tennessee,...
Knome and Personal Genomics to Form Sales Alliance and Scientific Partnership
CAMBRIDGE, MA, USA, April 11, 2014 – Knome, Inc. and Personal Genomics, s.r.l., Verona, Italy, announced an exclusive sales alliance for Knome’s knoSYS™ platform in Italy and a scientific partnership for continued development of the platform’s tools, content, and...
Knome Appoints Hugh Y. Rienhoff, Jr., MD to Scientific Advisory Board
Dr. Rienhoff brings deep industry and technical expertise as Knome continues to expand CAMBRIDGE, MA – April 3, 2012 – Knome, Inc., the human genome interpretation company, today announced that it has continued to expand its scientific advisory board to include...
Knome Closes $13 Million Financing Round
CAMBRIDGE, MA – January 10, 2014 – Knome, Inc. announced that it has successfully closed a $13 Million financing round led by current investors. The funds will be used to promote growth and expansion of its genomic services and software systems businesses. Since 2007,...
Omixon and Knome Partner to Offer Advanced HLA Typing for Whole Genome and Exome Level Data
CAMBRIDGE, MA — June 3, 2013 — Knome Inc., the human genome interpretation company, today announced that its Services division will now provide its clients with advanced HLA typing capabilities as part of its whole genome and exome interpretation offerings. These...
Knome Appoints Heidi L. Rehm, PhD to Scientific Advisory Board
Dr. Rehm brings deep experience in clinical genomics and patient care as Knome continues to expand CAMBRIDGE, MA – July 9, 2012 – Knome Inc., the human genome interpretation company, announced today that a leading clinical geneticist, Heidi Rehm, PhD, has...
Knome Selected as a Genome Interpretation Partner for Illumina Genome Network
Firms partner to offer Illumina’s high-quality genome sequencing services in combination with Knome’s advanced genome interpretation solutions CAMBRIDGE, MA – April 3, 2012 – Knome Inc., the human genome interpretation company, announced today that it has been...
Knome Expands Scientific Advisory Board
Drs. David Goldstein and Yaniv Erlich bring genomics expertise as company pursues future growth CAMBRIDGE, MA – January 9, 2012 – Knome, Inc., the human genome interpretation company, today announced that it has expanded its scientific advisory board to include...
Knome Selected as Technology Partner by Johns Hopkins for Landmark 1,000 Genomes Asthma Research
Knome’s informatics and software tools to be used to interpret whole genomes of African American and African Caribbean asthma patients CAMBRIDGE, MA – January 9, 2012 – Knome, Inc., the human genome interpretation company, today announced that it has been...